Immunohistochemistry Market Scope And Analysis

  • Report Code : TIPRE00006184
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 259
Buy Now

Immunohistochemistry Market Analysis, Trends, and Scope 2022 to 2028

Buy Now


Immunohistochemistry Market Report Scope

Report Attribute Details
Market size in 2021 US$ 2.17 Billion
Market Size by 2028 US$ 3.59 Billion
Global CAGR (2021 - 2028) 7.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Application
  • Diagnostics
  • Drug Testing
By Product
  • Antibodies
  • Equipment
  • Reagents
  • Kits
By End User
  • Hospitals and Diagnostic Laboratories
  • Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F Hoffmann LA Roche AG
  • Merck KGaA
  • PerkinElmer Inc
  • Thermo Fisher Scientific Inc
  • Abcam Plc
  • Agilent Technologies
  • Bio SB
  • Bio Rad Laboratories
  • Cell Signaling Technology Inc
  • Covid-19 Impact:

    The breakout of the COVID-19 pandemic in North America had a significant impact on the United States. The country has the highest number of patients who have tested positive. Various healthcare research centers across the country were solely focused on COVID 19 treatments. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

    Competitive Landscape and Key Companies:

    Some of the prominent players operating in the global immunohistochemistry market include F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share.